{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:54:37Z","timestamp":1781740477806,"version":"3.54.5"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbrep.2026.102595","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T20:50:51Z","timestamp":1777236651000},"page":"102595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["LncRNA AFAP1-AS1 mediates therapy-dependent expression of CCL5, CXCL10 and MMP9 in multiple sclerosis"],"prefix":"10.1016","volume":"46","author":[{"given":"Lina Nasser","family":"Hegazy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya Aly","family":"Elkhodiry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Hamed","family":"Rashad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramez Reda","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2392-7436","authenticated-orcid":false,"given":"Hend Mohamed","family":"El Tayebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2026.102595_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1\u20132","key":"10.1016\/j.bbrep.2026.102595_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2011.03.003","article-title":"Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms","volume":"234","author":"Greer","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102595_bib3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbadis.2010.06.017","article-title":"Disruption of central nervous system barriers in multiple sclerosis","volume":"1812","author":"Alvarez","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.bbrep.2026.102595_bib4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.bbrep.2026.102595_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrneurol.2010.91","article-title":"Multiple sclerosis genetics\u2014is the glass half full, or half empty?","volume":"6","author":"Oksenberg","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"4\u20135","key":"10.1016\/j.bbrep.2026.102595_bib6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0171-2985(96)80024-6","article-title":"Macrophages in multiple sclerosis","volume":"195","author":"Br\u00fcck","year":"1996","journal-title":"Immunobiology"},{"key":"10.1016\/j.bbrep.2026.102595_bib7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2019.00286","article-title":"Targeting microglia and macrophages: a potential treatment strategy for multiple sclerosis","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102595_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/icb.2008.99","article-title":"Type II\u2010activated macrophages suppress the development of experimental autoimmune encephalomyelitis","volume":"87","author":"Tierney","year":"2009","journal-title":"Immunol. Cell Biol."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102595_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/imm.12608","article-title":"Emerging role of microRNAs in regulating macrophage activation and polarization in immune response and inflammation","volume":"148","author":"Wu","year":"2016","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.bbrep.2026.102595_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-5728(97)00208-7","article-title":"Expression of monocyte chemoattractant protein-1 and other \u03b2-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions","volume":"84","author":"Simpson","year":"1998","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102595_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-3083.1997.d01-100.x","article-title":"Perivascular T cells Express the pro\u2010inflammatory chemokine RANTES mRNA in multiple sclerosis lesions","volume":"46","author":"Hvas","year":"1997","journal-title":"Scand. J. Immunol."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102595_bib12","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/jnnp.73.3.320","article-title":"Expression of chemokines in cerebrospinal fluid and serum of patients with chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Mahad","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbrep.2026.102595_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1468-1331.2004.00951.x","article-title":"The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease","volume":"12","author":"Bartosik\u2010Psujek","year":"2005","journal-title":"Eur. J. Neurol."},{"issue":"7","key":"10.1016\/j.bbrep.2026.102595_bib14","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.4049\/jimmunol.172.7.4018","article-title":"Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous System and reduced neurologic disease in a viral model of multiple sclerosis","volume":"172","author":"Glass","year":"2004","journal-title":"J. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.bbrep.2026.102595_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0165-5728(02)00097-8","article-title":"Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system","volume":"127","author":"S\u00f8rensen","year":"2002","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.bbrep.2026.102595_bib16","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.4049\/jimmunol.154.10.5235","article-title":"The interferon-stimulated response element and a kappa B site mediate synergistic induction of murine IP-10 gene transcription by IFN- gamma and TNF- alpha","volume":"154","author":"Ohmori","year":"1995","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.bbrep.2026.102595_bib17","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/1521-4141(200207)32:7<2037::AID-IMMU2037>3.0.CO;2-I","article-title":"TNF\u03b1-induced macrophage chemokine secretion is more dependent on NF-\u03baB expression than lipopolysaccharides-induced macrophage chemokine secretion","volume":"32","author":"Ciesielski","year":"2002","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.bbrep.2026.102595_bib18","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.4049\/jimmunol.1103474","article-title":"NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-\u03b3 and perforin-dependent mechanisms","volume":"189","author":"Ge","year":"2012","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.bbrep.2026.102595_bib19","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.4049\/jimmunol.163.11.6236","article-title":"Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-Infected liver","volume":"163","author":"Shields","year":"1999","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102595_bib20","doi-asserted-by":"crossref","first-page":"514","DOI":"10.15537\/1658-3175.3848","article-title":"Expression of CXC chemokine IP-10\/Mob-1 by primary hepatocytes following heat shock","volume":"28","author":"Hassanshahi","year":"2007","journal-title":"Saudi Med. J."},{"issue":"6","key":"10.1016\/j.bbrep.2026.102595_bib21","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1172\/JCI5150","article-title":"Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients","volume":"103","author":"S\u00f8rensen","year":"1999","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102595_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-2990.2000.026002133.x","article-title":"Expression of the interferon\u2010\u03b3\u2010inducible chemokines IP\u201010 and Mig and their receptor, CXCR3, in multiple sclerosis lesions","volume":"26","author":"Simpson","year":"2000","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"12","key":"10.1016\/j.bbrep.2026.102595_bib23","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.1073\/pnas.96.12.6873","article-title":"CCR5 + and CXCR3 + T cells are increased in multiple sclerosis and their ligands MIP-1\u03b1 and IP-10 are expressed in demyelinating brain lesions","volume":"96","author":"Balashov","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"6","key":"10.1016\/j.bbrep.2026.102595_bib24","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1189\/jlb.0607338","article-title":"Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation","volume":"82","author":"Van Lint","year":"2007","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102595_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bbamcr.2009.07.004","article-title":"Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models","volume":"1803","author":"Fanjul-Fern\u00e1ndez","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.bbrep.2026.102595_bib26","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1172\/JCI6886","article-title":"Resistance of young gelatinase B\u2013deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions","volume":"104","author":"Dubois","year":"1999","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.bbrep.2026.102595_bib27","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/35081571","article-title":"Metalloproteinases in biology and pathology of the nervous system","volume":"2","author":"Yong","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"issue":"9","key":"10.1016\/j.bbrep.2026.102595_bib28","doi-asserted-by":"crossref","first-page":"18790","DOI":"10.3390\/ijms140918790","article-title":"Long non-coding RNAs and complex human diseases","volume":"14","author":"Li","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2026.102595_bib29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.msard.2018.07.044","article-title":"Dysregulation of long non-coding RNA profile in peripheral blood of multiple sclerosis patients","volume":"25","author":"Dastmalchi","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102595_bib30","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2174\/0113892029358348250124064940","article-title":"YY2 serves as a novel prognostic biomarker correlated with immune microenvironment and glycolysis in esophageal carcinoma","volume":"26","author":"Gou","year":"2025","journal-title":"Curr. Genom."},{"issue":"11","key":"10.1016\/j.bbrep.2026.102595_bib31","doi-asserted-by":"crossref","first-page":"862","DOI":"10.2174\/0109298665335550241011080252","article-title":"Exploring the therapeutic potential of noncoding RNAs in alzheimer's disease","volume":"31","author":"Tripathi","year":"2024","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.bbrep.2026.102595_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/0118761429374180250212114144","article-title":"Dihydromyricetin improves myocardial functioning by influencing autophagy through SNHG17\/Mir 34a\/SIDT2 axis","volume":"17","author":"Xiao","year":"2025","journal-title":"Curr. Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102595_bib33","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2174\/0113892029345945241125064704","article-title":"Role of long noncoding RNA Dio3os in glycolipid metabolism","volume":"26","author":"Wang","year":"2025","journal-title":"Curr. Genom."},{"key":"10.1016\/j.bbrep.2026.102595_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/0118761429308361240823061634","article-title":"Recent advances in the glycolytic processes linked to tumor metastasis","volume":"17","author":"Qiong","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbrep.2026.102595_bib35","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1053\/j.gastro.2013.01.019","article-title":"Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's Esophagus and esophageal adenocarcinoma","volume":"144","author":"Wu","year":"2013","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bbrep.2026.102595_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.canlet.2014.03.029","article-title":"Antisense long non-coding RNA PCNA-AS1 promotes tumor growth by regulating proliferating cell nuclear antigen in hepatocellular carcinoma","volume":"349","author":"Yuan","year":"2014","journal-title":"Cancer Lett."},{"issue":"44","key":"10.1016\/j.bbrep.2026.102595_bib37","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.1038\/sj.onc.1204784","article-title":"The actin filament-associated protein AFAP-110 is an adaptor protein that modulates changes in actin filament integrity","volume":"20","author":"Baisden","year":"2001","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bbrep.2026.102595_bib38","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3892\/ijmm.2014.1946","article-title":"Inhibition of Src phosphorylation reduces damage to the blood-brain barrier following transient focal cerebral ischemia in rats","volume":"34","author":"Bai","year":"2014","journal-title":"Int. J. Mol. Med."},{"issue":"7","key":"10.1016\/j.bbrep.2026.102595_bib39","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1172\/JCI60842","article-title":"Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease","volume":"122","author":"Argaw","year":"2012","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102595_bib40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1871527314666150116125246","article-title":"The blood-brain barrier in multiple sclerosis: microRNAs as key regulators","volume":"14","author":"Kamphuis","year":"2015","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"issue":"24","key":"10.1016\/j.bbrep.2026.102595_bib41","doi-asserted-by":"crossref","first-page":"20404","DOI":"10.18632\/oncotarget.4057","article-title":"Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma","volume":"6","author":"Bo","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrep.2026.102595_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2021.774002","article-title":"Long non-coding RNAs , novel offenders or guardians in multiple sclerosis : a scoping review","volume":"12","author":"Jalaiei","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrep.2026.102595_bib43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/1874312901206010259","article-title":"Signal transduction pathways in chronic inflammatory Autoimmune disease: small GTPases","volume":"6","author":"Reedquist","year":"2012","journal-title":"Open Rheumatol. J."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102595_bib44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/cen3.12513","article-title":"Long non-coding RNA AFAP1-AS1 is upregulated in a subset of multiple sclerosis patients","volume":"10","author":"Mazdeh","year":"2019","journal-title":"Clin .Exp. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102595_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/imm.13125","article-title":"Monocyte isolation techniques significantly impact the phenotype of both isolated monocytes and derived macrophages in vitro","volume":"159","author":"Nielsen","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.bbrep.2026.102595_bib46","doi-asserted-by":"crossref","first-page":"23956","DOI":"10.1038\/s41598-024-75376-3","article-title":"A protocol to isolate and characterize pure monocytes and generate monocyte-derived dendritic cells through FBS-Coated flasks","volume":"14","author":"Meskini","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2026.102595_bib47","doi-asserted-by":"crossref","first-page":"S825","DOI":"10.1007\/s100720070020","article-title":"Age at onset in multiple sclerosis","volume":"21","author":"Liguori","year":"2000","journal-title":"Neurol. Sci."},{"issue":"7","key":"10.1016\/j.bbrep.2026.102595_bib48","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/brainsci7070078","article-title":"Multiple sclerosis: immunopathology and treatment update","volume":"7","author":"Dargahi","year":"2017","journal-title":"Brain Sci."},{"key":"10.1016\/j.bbrep.2026.102595_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2018.02.015","article-title":"The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"318","author":"Chu","year":"2018","journal-title":"J. Neuroimmunol."},{"issue":"11","key":"10.1016\/j.bbrep.2026.102595_bib50","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.2337\/db11-1635","article-title":"Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice","volume":"61","author":"Parsa","year":"2012","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.bbrep.2026.102595_bib51","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/icb.2016.34","article-title":"Human macrophages induce CD4(+)Foxp3(+) regulatory T cells via binding and re-release of TGF-\u03b2","volume":"94","author":"Schmidt","year":"2016","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.bbrep.2026.102595_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-018-0586-9","article-title":"Noncoding RNAs in multiple sclerosis","volume":"10","author":"Yang","year":"2018","journal-title":"Clin. Epigenet."},{"issue":"18","key":"10.1016\/j.bbrep.2026.102595_bib53","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1089\/ars.2012.5068","article-title":"Multiple sclerosis: molecular mechanisms and therapeutic opportunities","volume":"19","author":"Miljkovi\u0107","year":"2013","journal-title":"Antioxidants Redox Signal."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102595_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121488","article-title":"Fingolimod prevents blood-brain barrier disruption induced by the sera from patients with multiple sclerosis","volume":"10","author":"Nishihara","year":"2015","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.bbrep.2026.102595_bib55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11481-023-10059-w","article-title":"Inflammatory cytokines associated with multiple sclerosis directly induce alterations of neuronal cytoarchitecture in human neurons","volume":"18","author":"Meyer-Arndt","year":"2023","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102595_bib56","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.clineuro.2005.01.005","article-title":"Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing\u2013remitting multiple sclerosis treated with interferon beta","volume":"108","author":"Boz","year":"2006","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102595_bib57","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1191\/1352458505ms1193oa","article-title":"Serum MMP-9\/TIMP-1 and MMP-2\/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment","volume":"11","author":"Avolio","year":"2005","journal-title":"Mult. Scler."},{"key":"10.1016\/j.bbrep.2026.102595_bib58","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.expneurol.2015.02.022","article-title":"Dimethyl fumarate attenuates cerebral edema formation by protecting the blood\u2013brain barrier integrity","volume":"266","author":"Kunze","year":"2015","journal-title":"Exp. Neurol."},{"issue":"7","key":"10.1016\/j.bbrep.2026.102595_bib59","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/WNL.53.7.1402","article-title":"Changes of serum sICAM-1 and MMP-9 induced by rIFN\u03b2-1b treatment in relapsing-remitting MS","volume":"53","author":"Trojano","year":"1999","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.bbrep.2026.102595_bib60","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s00415-003-0191-4","article-title":"Interferon- \u03b2 -1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis","volume":"250","author":"Yushchenko","year":"2003","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbrep.2026.102595_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577065","article-title":"Impact of fingolimod on CD4+ T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients","volume":"337","author":"K\u00fcrt\u00fcnc\u00fc","year":"2019","journal-title":"J. Neuroimmunol."},{"issue":"1\u20132","key":"10.1016\/j.bbrep.2026.102595_bib62","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0165-5728(00)00397-0","article-title":"Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1\u03b1 by interferon-\u03b2","volume":"112","author":"Zang","year":"2001","journal-title":"J. Neuroimmunol."},{"issue":"1\u20132","key":"10.1016\/j.bbrep.2026.102595_bib63","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2011.05.024","article-title":"Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-\u03b2 1a treated multiple sclerosis patients","volume":"307","author":"Christophi","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102595_bib64","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200050","article-title":"Serum levels of CXCL13 are associated with teriflunomide response in patients with multiple sclerosis","volume":"10","author":"Fissolo","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"10.1016\/j.bbrep.2026.102595_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103446","article-title":"Serological markers exploration and real-world effectiveness and safety of teriflunomide in south Chinese patients with multiple sclerosis","volume":"58","author":"Zhou","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.bbrep.2026.102595_bib66","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1189\/jlb.0504308","article-title":"Modulation of effector cell functions in experimental autoimmune encephalomyelitis by leflunomide\u2014 mechanisms independent of pyrimidine depletion","volume":"76","author":"Korn","year":"2004","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102595_bib67","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/acn3.711","article-title":"Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients","volume":"6","author":"Medina","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"7","key":"10.1016\/j.bbrep.2026.102595_bib68","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1194\/jlr.M084202","article-title":"Identification of an acid sphingomyelinase ceramide kinase pathway in the regulation of the chemokine CCL5","volume":"59","author":"Newcomb","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrep.2026.102595_bib69","series-title":"Encyclopedia of Hormones","first-page":"255","article-title":"CC, C, and CX3C chemokines","author":"Rabin","year":"2003"},{"issue":"12","key":"10.1016\/j.bbrep.2026.102595_bib70","doi-asserted-by":"crossref","first-page":"6180","DOI":"10.4049\/jimmunol.164.12.6180","article-title":"TNF-\u03b1-Induced secretion of C-C chemokines modulates C-C chemokine receptor 5 expression on peripheral blood lymphocytes","volume":"164","author":"Hornung","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrep.2026.102595_bib71","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12974-015-0393-6","article-title":"Fingolimod induces neuroprotective factors in human astrocytes","volume":"12","author":"Hoffmann","year":"2015","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.bbrep.2026.102595_bib72","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/1744666X.2018.1426462","article-title":"Interferon \u03b2-1a and \u03b2-1b for patients with multiple sclerosis: updates to current knowledge","volume":"14","author":"Zettl","year":"2018","journal-title":"Expet Rev. Clin. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.bbrep.2026.102595_bib73","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jneuroim.2004.07.016","article-title":"Interferon-\u03b2 induces transient systemic IP-10\/CXCL10 chemokine release in patients with multiple sclerosis","volume":"156","author":"Buttmann","year":"2004","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.bbrep.2026.102595_bib74","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1046\/j.1365-2133.2001.04220.x","article-title":"The antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cells","volume":"144","author":"Stoof","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bbrep.2026.102595_bib75","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fnmol.2016.00084","article-title":"NF-\u03baB pathways in the pathogenesis of multiple sclerosis and the therapeutic implications","volume":"9","author":"Leibowitz","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbrep.2026.102595_bib76","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12974-017-0829-2","article-title":"Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicity","volume":"14","author":"Ambrosius","year":"2017","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.bbrep.2026.102595_bib77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-3083.2006.01788.x","article-title":"Dynamic t\u2010lymphocyte chemokine receptor expression induced by interferon\u2010beta therapy in multiple sclerosis","volume":"64","author":"Krakauer","year":"2006","journal-title":"Scand. J. Immunol."},{"issue":"10","key":"10.1016\/j.bbrep.2026.102595_bib78","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1001\/archneurol.2009.138","article-title":"Enhancement of chemokine expression by interferon beta therapy in patients with multiple sclerosis","volume":"66","author":"Cepok","year":"2009","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102595_bib79","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clim.2009.05.019","article-title":"Interferon-\u03b2 treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1","volume":"133","author":"Christophi","year":"2009","journal-title":"Clin. Immunol."},{"issue":"9","key":"10.1016\/j.bbrep.2026.102595_bib80","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1167\/iovs.06-1234","article-title":"Positive feedback regulation between MMP-9 and VEGF in human RPE cells","volume":"48","author":"Hollborn","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102595_bib81","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ana.24217","article-title":"Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide","volume":"76","author":"Colombo","year":"2014","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.bbrep.2026.102595_bib82","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.4049\/jimmunol.178.9.5425","article-title":"Cutting edge: alternative signaling of Th17 cell development by sphingosine 1-Phosphate","volume":"178","author":"Liao","year":"2007","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102595_bib83","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/jcp.21869","article-title":"Cytokines and signaling pathways regulating matrix metalloproteinase\u20109 (MMP\u20109) expression in corneal epithelial cells","volume":"221","author":"Gordon","year":"2009","journal-title":"J. Cell. Physiol."},{"issue":"11","key":"10.1016\/j.bbrep.2026.102595_bib84","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s11910-013-0394-8","article-title":"Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects","volume":"13","author":"Linker","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102595_bib85","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2478\/raon-2019-0057","article-title":"Cytokine CCL5 and receptor CCR5 axis in glioblastoma multiforme","volume":"53","author":"Kranjc","year":"2019","journal-title":"Radiol. Oncol."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102595_bib86","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-0033-1343794","article-title":"Fingolimod therapy for multiple sclerosis","volume":"33","author":"Willis","year":"2013","journal-title":"Semin. Neurol."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102595_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031372","article-title":"Response to fingolimod in multiple sclerosis patients is associated with a differential transcriptomic regulation","volume":"25","author":"S\u00e1nchez-Sanz","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bbrep.2026.102595_bib88","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/11591110-000000000-00000","article-title":"The mechanism of action of Interferon-\u03b2 in relapsing multiple sclerosis","volume":"25","author":"Kieseier","year":"2011","journal-title":"CNS Drugs"},{"issue":"1_supplement_1","key":"10.1016\/j.bbrep.2026.102595_bib89","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e3181c97d99","article-title":"Interferon-\u03b2 mechanisms of action in multiple sclerosis","volume":"74","author":"Dhib-Jalbut","year":"2010","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.bbrep.2026.102595_bib90","doi-asserted-by":"crossref","DOI":"10.4161\/sgtp.29710","article-title":"Rho GTPases","volume":"5","author":"Sadok","year":"2014","journal-title":"Small GTPases"},{"issue":"12","key":"10.1016\/j.bbrep.2026.102595_bib91","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/cells7120263","article-title":"Post-Translational modification and subcellular distribution of Rac1: an update","volume":"7","author":"Abdrabou","year":"2018","journal-title":"Cells"},{"issue":"15","key":"10.1016\/j.bbrep.2026.102595_bib92","doi-asserted-by":"crossref","first-page":"R535","DOI":"10.1016\/S0960-9822(07)00341-7","article-title":"Lymphocyte signalling: a coordinating role for Vav?","volume":"8","author":"Cantrell","year":"1998","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102595_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010166","article-title":"MMP-9 signaling pathways that engage rho GTPases in brain plasticity","volume":"10","author":"Figiel","year":"2021","journal-title":"Cells"},{"issue":"22","key":"10.1016\/j.bbrep.2026.102595_bib94","doi-asserted-by":"crossref","first-page":"15328","DOI":"10.1074\/jbc.M114.547349","article-title":"Tumor necrosis factor (TNF)-\u03b1 induction of CXCL10 in endothelial cells requires protein arginine methyltransferase 5 (PRMT5)-mediated nuclear factor (NF)-\u03baB p65 methylation","volume":"289","author":"Harris","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102595_bib95","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1101\/gad.11.4.463","article-title":"Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins","volume":"11","author":"Perona","year":"1997","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102595_bib96","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1042\/BSR20140021","article-title":"Rho protein GTPases and their interactions with NF\u03baB: crossroads of inflammation and matrix biology","volume":"34","author":"Tong","year":"2014","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bbrep.2026.102595_bib97","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cyto.2017.02.006","article-title":"Interferon regulatory factor signaling in autoimmune disease","volume":"98","author":"Matta","year":"2017","journal-title":"Cytokine"},{"issue":"9","key":"10.1016\/j.bbrep.2026.102595_bib98","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/acn3.92","article-title":"Increased CXCL10 expression in MS MSCs and monocytes is unaffected by AHSCT","volume":"1","author":"Bonechi","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102595_bib99","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1128\/JVI.02007-13","article-title":"Direct, interferon-independent activation of the CXCL10 promoter by NF-\u03baB and interferon regulatory factor 3 during hepatitis C virus infection","volume":"88","author":"Brownell","year":"2014","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.bbrep.2026.102595_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128757","article-title":"Effect of JAK inhibitors on release of CXCL9, CXCL10 and CXCL11 from human airway epithelial cells","volume":"10","author":"Fenwick","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2026.102595_bib101","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clim.2016.09.014","article-title":"Role of the JAK\/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases","volume":"189","author":"Yan","year":"2018","journal-title":"Clin. Immunol."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240558082600155X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240558082600155X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:36:35Z","timestamp":1781739395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240558082600155X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":101,"alternative-id":["S240558082600155X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102595","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LncRNA AFAP1-AS1 mediates therapy-dependent expression of CCL5, CXCL10 and MMP9 in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102595","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102595"}}